Anticancer Research · 2018 · 36 citations · 16 references
MedicineOncologyPharmacologyApoptosisEnzymologyMolecular OncologyAcetyl-coa Carboxylase InhibitionApoptosis PharmacologyEnzyme InhibitionFatty Acid BiosynthesisPancreatic CancerAcetyl-coa Carboxylase EnzymeAcetyl-coenzyme A Carboxylase InhibitionAnnexin V AssaysAnnexin V ImagingAnnexin-based ImagingAnticancer ActivityCell Death AssaysRate-limiting Enzymes
BACKGROUND/AIM: Acetyl-CoA carboxylase (ACC) is a rate-limiting enzyme in fatty acid synthesis. In this study, we investigated the effect of ACC inhibition on survival of pancreatic cancer cells. MATERIAL AND METHODS: AsPC-1, BxPC-3 and PANC-1 were used as human pancreatic cancer cell lines. 5-(etradecyloxy)-2-furoic acid (TOFA) and bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl) ethyl sulfide (BPTES) were used as inhibitors of ACC and glutaminase (GLS) respectively. Apoptotic and live cells were distinguished by annexin-V staining. The activity of caspase-3 was evaluated by measuring the fluorescence intensity of the degradation product of the substrate, N-acetyl-Asp-Glu-Val-Asp-7-amido-4-trifluoromethylcoumarin. RESULTS: TOFA increased the number of annexin V-positive cells and enhanced caspase-3 activity in AsPC-1 and BxPC-3, but not in PANC-1 cells. The number of PANC-1 cells increased after 48 h in Earle's balanced salt solution. Interestingly, proliferation of PANC-1 cells was drastically suppressed by glutamine deprivation, but not by inhibition of glycolysis. BPTES also induced cell death to the same extent as glutamine deprivation. In addition, TOFA induced cell death of PANC-1 cells, both in the presence of BPTES and with glutamine deprivation, suggesting that inhibition of glutaminolysis causes cell death and enhances the effect of TOFA in PANC-1 cells. CONCLUSION: These findings suggest that glutaminolysis is important for the survival of pancreatic cancer cells showing tolerance to nutrient starvation such as PANC-1 cells, and use of a combination of inhibitors of ACC and GLS may be a new strategy for treatment of pancreatic cancer.
16
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff, Thomas J. Ervin, Francis P. Arena et al. · New England Journal of Medicine · 2013 · 6.7K citations
Medicine, Oncology, Pharmacology +13
ATP citrate lyase inhibition can suppress tumor cell growth
Georgia Hatzivassiliou, Fangping Zhao, Daniel E. Bauer et al. · Cancer Cell · 2005 · 1.1K citations · Full text
Megumi Hori, Tomohiro Matsuda, Akiko Shibata et al. · Japanese Journal of Clinical Oncology · 2015 · 621 citations · Full text
Modulating the therapeutic response of tumours to dietary serine and glycine starvation
Oliver D.K. Maddocks, Dimitris Athineos, Eric C. Cheung et al. · Nature · 2017 · 619 citations
Medicine, Cancer Biology, Oncology +16
ATP citrate lyase is an important component of cell growth and transformation
Daniel E. Bauer, Georgia Hatzivassiliou, Fangping Zhao et al. · Oncogene · 2005 · 535 citations